Latest filing published 20 Nov 2009 for SERACARE LIFE SCIENCES INC, €8,891.
Insider track record
No signal scores available.
Mark Manak: trading record in brief
Mark Manak discloses dealings in Seracare Life Sciences Inc to SEC (Form 4). Between 1 July 2009 and 18 November 2009, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 20 November 2009: a share grant of €8,891, in Seracare Life Sciences Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Manak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,432 shares@ US$3.00Common StockSEC:0001209191-09-053879:0
- 900 shares0Common StockSEC:0001209191-09-047014:0
- 1,906 shares0Common StockSEC:0001209191-09-035401:0
3 of 3 declarations